Alzheimer’s Disease

Alzheimer’s disease affects approximately 5.1 million Americans, and that number is expected to increase by 50% by 2030.  Current therapies for Alzheimer patients provide only mild, transient symptomatic relief.  There is a significant unmet need for improved drugs that can modify the underlying course of disease.  Over $4 billion in revenues are currently generated by four digits.